Qiagen NV | QIA - Debt


Qiagen NV reported $1.65B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
argenx SE USD 47.16M 4.01M Dec/2025
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Moderna USD 1.3B 7M Mar/2026
Organon & Co USD 8.55B 16M Jun/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
Revvity USD 3.35B 48.03M Mar/2026
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 13.35B 993.3M Jun/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026